Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sepsis-associated delirium.

Marion Ebersoldt1, Tarek Sharshar, Djillali Annane

  • 1Université de Versailles Saint Quentin, Service de Réanimation Médicale, Hôpital Raymond Poincaré (AP-HP), 104 Boulevard Raymond Poincaré, 92380 Garches, France.

Intensive Care Medicine
|April 6, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HydrOcortisone and fludRocortisoNe for critical ILLness-related corticosteroid insufficiency (HORNbILL): study protocol for a multicentre randomised placebo-controlled trial.

BMJ open·2026
Same author

Ivermectin for Critically and Noncritically Ill Hospitalized Patients With COVID-19: Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community-Acquired Pneumonia (REMAP-CAP).

Critical care medicine·2026
Same author

High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodies.

medRxiv : the preprint server for health sciences·2026
Same author

Rethinking fairness in unsupervised healthcare AI: A methodological scoping review.

Journal of biomedical informatics·2026
Same author

Real-world effectiveness and safety of zilucoplan in patients with anti-AChR myasthenia gravis: A retrospective cohort study in France.

Journal of neuromuscular diseases·2026
Same author

Intermediate dose heparin thromboprophylaxis among critically ill patients with COVID-19: a randomized clinical trial.

Journal of thrombosis and haemostasis : JTH·2026
Same journal

From size to function: moving beyond body mass index to frailty and central adiposity phenotypes.

Intensive care medicine·2026
Same journal

Effects of a clinical metagenomics intervention on clinical outcomes, healthcare costs, and health-related quality of life in patients with sepsis or septic shock: results of the randomized-controlled DigiSep trial.

Intensive care medicine·2026
Same journal

Hypercalcemia in intensive care unit: pathophysiological mechanisms and clinical implications.

Intensive care medicine·2026
Same journal

EIT in ARDS: what we know and what we still do not.

Intensive care medicine·2026
Same journal

Burden of and risk factors for neurological complications in critical illness.

Intensive care medicine·2026
Same journal

Family support in intensive care: beyond no effect trials and the hidden challenges of cluster randomization.

Intensive care medicine·2026
See all related articles

Sepsis-associated delirium, a brain dysfunction in sepsis, involves vascular damage and inflammation. Diagnosis uses clinical and electrophysiological methods, with treatment focusing on managing sepsis itself.

Area of Science:

  • Neurology
  • Critical Care Medicine
  • Infectious Diseases

Background:

  • Sepsis-associated delirium is a frequent neurological complication of sepsis.
  • Understanding the mechanisms of sepsis-associated brain dysfunction is crucial.

Purpose of the Study:

  • To review diagnostic criteria for sepsis-associated delirium.
  • To update treatment strategies for sepsis-associated delirium.
  • To summarize current knowledge on the mechanisms of sepsis-associated brain dysfunction.

Main Methods:

  • Literature search of Medline (1981-2006) using keywords 'encephalopathy' and 'sepsis'.
  • Hand searching of cited articles from identified publications.
  • Review of immune response in sepsis leading to multiorgan failure, including brain dysfunction.

Related Experiment Videos

Main Results:

  • Potential mechanisms include vascular damage, endothelial activation, blood-brain barrier disruption, metabolic issues, neuroinflammation, and apoptosis.
  • Neuroprotective factors like anti-inflammatory mediators and glial cell activity are also implicated.
  • Diagnosis relies on clinical and electrophysiological assessments.

Conclusions:

  • Sepsis-associated delirium mechanisms are multifactorial, involving both damaging and protective pathways.
  • Current treatment for sepsis-associated delirium is primarily supportive and focuses on sepsis management.
  • Further research is needed to elucidate specific therapeutic targets.